213 related articles for article (PubMed ID: 36959711)
1. Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models.
Draper GM; Panken DJ; Largaespada DA
Genes Chromosomes Cancer; 2023 Sep; 62(9):493-500. PubMed ID: 36959711
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
3. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.
Shojaei Baghini S; Gardanova ZR; Abadi SAH; Zaman BA; İlhan A; Shomali N; Adili A; Moghaddar R; Yaseri AF
Cell Mol Biol Lett; 2022 May; 27(1):35. PubMed ID: 35508982
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
[TBL] [Abstract][Full Text] [Related]
8. 65 YEARS OF THE DOUBLE HELIX: The advancements of gene editing and potential application to hereditary cancer.
Tan ZY; Huang T; Ngeow J
Endocr Relat Cancer; 2018 Aug; 25(8):T141-T158. PubMed ID: 29980644
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
10. CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
Baliou S; Adamaki M; Kyriakopoulos AM; Spandidos DA; Panayiotidis M; Christodoulou I; Zoumpourlis V
Int J Oncol; 2018 Aug; 53(2):443-468. PubMed ID: 29901119
[TBL] [Abstract][Full Text] [Related]
11. Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines.
Sayed S; Sürün D; Mircetic J; Sidorova OA; Buchholz F
Methods Mol Biol; 2022; 2508():235-260. PubMed ID: 35737245
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.
Liu B; Saber A; Haisma HJ
Drug Discov Today; 2019 Apr; 24(4):955-970. PubMed ID: 30849442
[TBL] [Abstract][Full Text] [Related]
13. New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer.
Ahmed M; Daoud GH; Mohamed A; Harati R
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34066014
[TBL] [Abstract][Full Text] [Related]
14. Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?
Mitra S; Sarker J; Mojumder A; Shibbir TB; Das R; Emran TB; Tallei TE; Nainu F; Alshahrani AM; Chidambaram K; Simal-Gandara J
Biomed Pharmacother; 2022 Jun; 150():113011. PubMed ID: 35483191
[TBL] [Abstract][Full Text] [Related]
15. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
16. The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice.
van der Weyden L; Jonkers J; Adams DJ
Curr Opin Genet Dev; 2021 Feb; 66():57-62. PubMed ID: 33429291
[TBL] [Abstract][Full Text] [Related]
17. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Wu HY; Cao CY
Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
[TBL] [Abstract][Full Text] [Related]
18. A glance at genome editing with CRISPR-Cas9 technology.
Barman A; Deb B; Chakraborty S
Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
[TBL] [Abstract][Full Text] [Related]
19. Applications and advances of CRISPR-Cas9 in cancer immunotherapy.
Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ
J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals.
Khan AH; Tye GJ; Noordin R
Mol Biotechnol; 2020 Sep; 62(9):401-411. PubMed ID: 32749657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
